Genelux Corp (GNLX)

Sep 18, 2026

Genelux Corporation Common Stock (NASDAQ: GNLX) Stock Price, News & Analysis - kalkine.com.au

Sep 18, 2026

Sep 17, 2026

Genelux CorporationCommon Stock (Nasdaq:GNLX) Stock Quote - The Chronicle-Journal

Sep 17, 2026

Sep 09, 2026

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy - Yahoo Finance

Sep 09, 2026

Sep 04, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Sep 04, 2026

Sep 03, 2026

Genelux chief scientific officer Yu Yong sells $26,658 of stock By Investing.com - Investing.com South Africa

Sep 03, 2026

Sep 03, 2026

Genelux Corporation Common Stock (NASDAQ: GNLX) Stock Price, News & Analysis - kalkine.ca

Sep 03, 2026

Sep 02, 2026

Genelux chief scientific officer Yu Yong sells $26,658 of stock By Investing.com - Investing.com Canada

Sep 02, 2026

Sep 02, 2026

Genelux CTO Joseph Cappello sells $28,112 in company stock By Investing.com - Investing.com Nigeria

Sep 02, 2026

Sep 02, 2026

Genelux CEO Zindrick sells $91,899 in common stock - Investing.com India

Sep 02, 2026

Sep 02, 2026

Genelux CEO Zindrick sells $91,899 in common stock - Investing.com

Sep 02, 2026

Sep 02, 2026

Genelux CTO Joseph Cappello sells $28,112 in company stock - Investing.com

Sep 02, 2026

Sep 02, 2026

Genelux CTO Joseph Cappello sells $28,112 in company stock By Investing.com - Investing.com Canada

Sep 02, 2026

Sep 02, 2026

Genelux chief scientific officer Yu Yong sells $26,658 of stock By Investing.com - Investing.com UK

Sep 02, 2026

Sep 02, 2026

Genelux chief scientific officer Yu Yong sells $26,658 of stock - investing.com

Sep 02, 2026

Aug 18, 2026

Benchmark reiterates Genelux stock rating on cancer therapy progress - Investing.com

Aug 18, 2026

Aug 18, 2026

Benchmark reiterates Genelux stock rating on cancer therapy progress - Investing.com

Aug 18, 2026

Aug 18, 2026

Equities Analysts Offer Predictions for Genelux Q3 Earnings - MarketBeat

Aug 18, 2026

Aug 18, 2026

Analysts Are Bullish on Top Healthcare Stocks: Auxly Cannabis Group (CBWTD), Genelux Corp. (GNLX) - The Globe and Mail

Aug 18, 2026

Aug 15, 2026

Genelux: Undervalued Oncolytic Virus Leader as Olvi-Vec Nears Key Phase 3 Ovarian Cancer Catalyst - TipRanks

Aug 15, 2026

Aug 15, 2026

Genelux (NASDAQ:GNLX) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 13, 2026

Genelux Reports Second Quarter 2026 Results and Advances Olvi-Vec Clinical Programs in Ovarian and Lung Cancer - Quiver Quantitative

Aug 13, 2026

Aug 13, 2026

Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates - Yahoo Finance

Aug 13, 2026

Aug 13, 2026

Genelux (NASDAQ:GNLX) Issues Earnings Results - MarketBeat

Aug 13, 2026

Aug 13, 2026

GENELUX Corp 6M 2026: Revenue $0 Net loss $(18.4M), EPS $(0.41) — 10-Q Summary - TradingView

Aug 13, 2026

Aug 13, 2026

Genelux (GNLX) deepens losses while funding Phase 3 cancer trial and warning on cash runway - Stock Titan

Aug 13, 2026

Aug 13, 2026

Genelux Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aug 12, 2026

Genelux Corp (GNLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026

Aug 07, 2026

Genelux Corp (GNLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aug 07, 2026

Aug 07, 2026

Genelux Corporation (GNLX) Slips 1.11% as Shares Test Support Near $2.54High Low Breadth - dars.gov.et

Aug 07, 2026

Aug 06, 2026

Insiders Sold Genelux At US$3.34, Meanwhile Stock Sits Near US$2.51 - Sahm

Aug 06, 2026

Jul 31, 2026

Genelux Corp expected to post a loss of 20 cents a shareEarnings Preview - TradingView

Jul 31, 2026

Jul 30, 2026

Genelux (GNLX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Jul 30, 2026

Jul 28, 2026

Genelux Corp (GNLX) Balance Sheet - tradingkey.com

Jul 28, 2026

Jul 27, 2026

Genelux Corp (GNLX) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Genelux Corp (GNLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 26, 2026

Genelux Corp (GNLX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026

Jul 26, 2026

Genelux Corp (GNLX) Income Statement - TradingKey

Jul 26, 2026

Jul 25, 2026

GNLX|Genelux Corp|Price:2.890|Chg%:-0.070 - TradingKey

Jul 25, 2026

Jul 25, 2026

Genelux Corp (GNLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026

Jul 24, 2026

Genelux (NASDAQ:GNLX) Shares Down 2.4%Should You Sell? - marketbeat.com

Jul 24, 2026

Jul 23, 2026

Genelux Corp (GNLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 23, 2026

Jul 02, 2026

Insider Shake-Up at Genelux Corp Sparks Investor Attention - TipRanks

Jul 02, 2026

Jul 02, 2026

GENELUX (NASDAQ: GNLX) director sells 12,000 shares to cover RSU tax bill - Stock Titan

Jul 02, 2026

Jul 01, 2026

[144] GENELUX Corp SEC Filing - Stock Titan

Jul 01, 2026

Jul 01, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 01, 2026

Jun 30, 2026

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer - The Manila Times

Jun 30, 2026

Jun 30, 2026

Genelux says Olvi-Vec may reawaken platinum response in ovarian cancer - Stock Titan

Jun 30, 2026

Jun 26, 2026

Genelux Corp. Actuals & Estimates (NASDAQ:GNLX) - TradingView

Jun 26, 2026

Jun 22, 2026

Genelux Corporation 8-K Filing: Company Details, Nasdaq Listing, and Emerging Growth Status (June 2026) - Minichart

Jun 22, 2026

Jun 22, 2026

Genelux elects director and ratifies auditor at annual shareholder meeting - Investing.com

Jun 22, 2026